检索结果 - Murad Guliyev
- Showing 1 - 4 results of 4
-
1
-
2
The Impact of Progesterone Receptor Status on Survival Outcomes in Metastatic Breast Cancer Patients Treated with First-Line CDK4/6 Inhibitors 由 Murad Guliyev, Ali Kaan Güren, Emre Özge, Rumeysa Çolak, Nargiz Majıdova, G. Sen, Shamkhal Safarov, Murat Günaltılı, Mehmet Cem Fidan, İlkay Gültürk, Mesut Yılmaz, İbrahim Vedat Bayoğlu, Nebi Serkan Demirci, Özkan Alan
出版 2025Artigo -
3
Sunitinib in metastatic renal cell carcinoma: clinical outcomes across risk groups in a Turkish Oncology Group Kidney Cancer Consortium 由 Hatice Bölek, Omer F. Kuzu, Elif Sertesen Çamöz, Sung Hoon Sim, Serhat Sekmek, Hilal Karakas, Selver Işık, Murad Guliyev, Abdullah Akkuş, Deniz Tural, Çağatay Arslan, Sema Sezgin Göksu, Özlem Nuray Sever, Nuri Karadurmuş, Cengiz Karaçin, Mehmet Alı Nahıt Şendur, Emre Yekedüz, Yüksel Ürün
出版 2025Artigo -
4
Evaluation of Dose Reduction Factors and Impact on Progression-Free Survival in Patients Treated with CDK 4/6 Inhibitors 由 Ali Kaan Güren, Murad Guliyev, Özkan Alan, Kenan Çadırcı, İpek Naz Belevi, İlkay Gültürk, Emre Özge, Erkam Kocaaslan, Yeşim Ağyol, Pınar Erel, Burak Paçacı, Mustafa Alperen Tunç, Nargiz Majıdova, Nadiye Sever, Abdüssamet Çelebi, Rukiye Arıkan Erdoğan, Selver Işık, Nebi Serkan Demirci, Murat Sarı, Umut Kefeli, İbrahim Vedat Bayoğlu
出版 2025Artigo
相关主题
Cancer
Internal medicine
Medicine
Oncology
Adverse effect
Biochemistry
Biology
Biomarker
Breast cancer
Cancer research
Clinical Oncology
Estrogen receptor
First line
Gastroenterology
Geometry
Kidney cancer
Linguistics
Logistic regression
Mathematics
Metastatic breast cancer
Multivariate analysis
Oestrogen receptor
Overall survival
Philosophy
Progesterone receptor
Progression-free survival
Reduction (mathematics)
Renal cell carcinoma
Retrospective cohort study
Sunitinib